Skip to main content

Advertisement

SpringerLink
Log in

Pertinacious prescription of practice paradigms: The ethical burden of coercive clinical guidelines

  • Invited Commentary
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Landau WM: Clinical Neuromythology IX: Pyramid sale in the bucket shop; DATATOP bottoms out. Neurology 1990, 40:1337–1339.

    PubMed  CAS  Google Scholar 

  2. Shapira AH, Obeso J, Aminoff MJ: Point of views. Timing of treatment initiation in Parkinson’s disease: a need for reappraisal? Ann Neurol 2006, 59:559–565.

    Article  Google Scholar 

  3. Zanettini R, Antonini A, Gatto G, et al.: Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. N Engl J Med 2007, 356:39–46.

    Article  PubMed  CAS  Google Scholar 

  4. Creely CE, Wozniak DF, Labruyere J, et al.: Low doses of memantine disrupt memory in adult rats. J Neurosci 2006, 26:3923–3932.

    Article  Google Scholar 

  5. Creely CE, Wozniak DF, Nardi A, et al.: Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain. Neurobiol Aging online 18 November 2006 (doi:10.1016/j.neurobiolaging.2006.10.020).

  6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581–1588.

    Article  Google Scholar 

  7. Bambauer KZ, Johnston SC, Bambauer DE, et al.: Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol 2006, 63:661–664.

    Article  PubMed  Google Scholar 

  8. Wolf SL, Winstein CJ, Miller JP, et al.: Effect of constraintinduced movement therapy on upper extremity function 3 to 9 months after stroke: The EXCITE Randomized Clinical Trial. JAMA 2006, 296:2095–2142.

    Article  PubMed  CAS  Google Scholar 

  9. Landau WM: Letter to the Editor: Stroking the stroke prevention numbers. Stroke 1995, 26:329.

    PubMed  CAS  Google Scholar 

  10. Bhatt DL, Fox KA, Hacke W, et al.: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006, 354:1706–1717.

    Article  PubMed  CAS  Google Scholar 

  11. The ESPIRIT Study Group: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPIRIT): randomized controlled trial. Lancet 2006, 367:1665–1673.

    Article  Google Scholar 

  12. Taubes G: The soft science of dietary fat. Science 2001, 291:2536–2545.

    Article  PubMed  CAS  Google Scholar 

  13. Landau WM: Is cholesterol a risk factor for stroke? No. Arch Neurol 1999, 56:1521–1524.

    Article  PubMed  CAS  Google Scholar 

  14. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549–559.

    Article  Google Scholar 

  15. Dobkin BH: Underappreciated statin-induced myopathic weakness causes disability. Neurorehabil Neural Repair 2005, 19:259–263.

    Article  PubMed  Google Scholar 

  16. Goldstein LB, Adams R, Alberts MJ, et al.: Primary prevention of ischemic stroke. Stroke 2006, 37:1583–1633.

    PubMed  Google Scholar 

  17. Kleindorfer D, Broderick J, Khoury J, et al.: The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke 2006, 37:2473–2478.

    Article  PubMed  Google Scholar 

  18. Suzuki T, Matsunaga N, Kohsaka S, et al.: Diagnostic patterns in the evaluation of patients hospitalized with syncope. Pace 2006, 29:1240–1244.

    PubMed  Google Scholar 

  19. Landau WM, Nelson DA: Clinical Neuromythology XV: Feinting science: neuro-cardiogenic syncope and collateral vasovagal confusion. Neurology 1996, 46:609–618.

    PubMed  CAS  Google Scholar 

  20. Landau WM: Clinical Neuromythology XIII: Neuroskepticism: sovereign remedy for the carotid sinus syndrome. Neurology 1994, 44:1570–1576.

    PubMed  CAS  Google Scholar 

  21. Jaffe AS, Landau WM, Wetzel RD: Resuscitation 2000: the need for improved data bases in regard to neurological outcomes. Resuscitation 1998, 37:65–66.

    Article  PubMed  CAS  Google Scholar 

  22. Landau WM: Iatrogenic epidemic involuntary dementia: impending harvest of the cardiopulmonary resuscitation rage. Curr Neurol Neurosci Rep 2001, 1:403–404.

    Article  PubMed  CAS  Google Scholar 

  23. Conroy SP, Luxton T, Dingwall R, et al.: Cardiopulmonary resuscitation in continuing care settings: time for a rethink? BMJ 2006, 332:479–482.

    Article  PubMed  Google Scholar 

  24. Kassirer JP, Angell M: Losing weight-an ill-fated New Year’s resolution [editorial]. N Engl J Med 1998, 338:52–54.

    Article  PubMed  CAS  Google Scholar 

  25. Nelson DA, Landau WM: Intraspinal steroids: history, efficacy, accidentality and controversy with review of United States Food and Drug Administration reports. Neurol Neurosurg Psychiatry 2001, 70:433–443.

    Article  CAS  Google Scholar 

  26. Weinstein JN, Tosteson TD, Lurie JD, et al.: Surgical vs nonoperative treatment for lumbar disk herniation: The Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA 2006, 296:2441–2450.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Washington University School of Medicine, 660 S. Euclid Avenue, Saint Louis, MO, 63110, USA

    William M. Landau

Authors
  1. William M. Landau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William M. Landau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Landau, W.M. Pertinacious prescription of practice paradigms: The ethical burden of coercive clinical guidelines. Curr Neurol Neurosci Rep 7, 355–358 (2007). https://doi.org/10.1007/s11910-007-0054-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-007-0054-y

Keywords

Search

Navigation